Tag: Alzheimer’s
Alzheimer Disease Gene Mapping Project Proposed in New York State
Governor says initiative will help researchers working to slow the progression of Alzheimer disease
Two Experimental Drugs for Rare, Inherited Alzheimer Disease Disappoint
Both drugs designed to target and neutralize amyloid beta in the brain
Road Proximity Linked to Incidence of Neurologic Diseases
Incidence increased for non-Alzheimer dementia, Parkinson, Alzheimer disease, multiple sclerosis
Suvorexant May Improve Insomnia With Alzheimer Disease
Suvorexant does not appear to worsen underlying cognitive impairment
Primary Care Screening for Dementia Not Harmful
No increases for depressive, anxiety symptoms seen with screening in rural, suburban, urban primary care clinics
Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease
TBI injury risk up for quetiapine versus risperidone users
Tau-PET Signal Predicts Atrophy in Early Alzheimer Disease
Association between baseline tau-PET and subsequent atrophy particularly strong in younger patients
2007 to 2014 Saw Decrease in U.S. Incidence of Alzheimer Disease
Incidence varied considerably by region, ranging from 0 to more than 3 percent across population areas in 2014
More Hospital Days Seen With Antipsychotic Use in Alzheimer Disease
Number of hospital days up by more than 50 percent in AD patients initiating antipsychotic medication
Dementia Common in Down Syndrome Patients Aged ≥55
Dementia incidence 102 cases per 1,000 person-years for individuals aged 55 years or older
